Skip to main content
SpringerLink
Log in

Neural effects of psychedelics: Complexity the key word

  • Research Highlight
  • Published:
Neuropsychopharmacology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Olson DE. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharm Transl Sci. 2021;4:563–7.

    Article  CAS  Google Scholar 

  2. Murray, CH, Frohlich J, Haggarty CJ, Tare I, Lee R, de Wit H Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacol. 1–9 (2024). https://doi.org/10.1038/s41386-024-01809-2.

  3. Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci. 2023;26:1032–41. https://doi.org/10.1038/s41593-023-01316-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones B, et al. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. BJPsych Open. 2023;9:e134.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ibarra-Lecue I, Mollinedo-Gajate I, Meana JJ, Callado LF, Diez-Alarcia R, Urigüen L. Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway. Neuropsychopharmacology. 2018;43:2028–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

BDMJ reports grants from the PSI Foundation, the University of Toronto and CIHR. MIH receives research support from the Brain and Behavior Research Foundation, Canadian Institutes of Health Research (CIHR), CAMH Foundation, Grand Challenges Canada, the PSI Foundation, and the University of Toronto. He has provided consultancy to Mindset Pharma, PsychEd Therapeutics, and Wake Network.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

    Brett D. M. Jones & M. Ishrat Husain

  2. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada

    Brett D. M. Jones & M. Ishrat Husain

Authors
  1. Brett D. M. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ishrat Husain
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both BDMJ and MIH drafted the manuscript.

Corresponding author

Correspondence to M. Ishrat Husain.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jones, B.D.M., Husain, M.I. Neural effects of psychedelics: Complexity the key word. Neuropsychopharmacol. 49, 1067–1068 (2024). https://doi.org/10.1038/s41386-024-01856-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41386-024-01856-9

  • Springer Nature Switzerland AG

Search

Navigation